Skip to main content
. 2016 Aug 12;9(3):3112–3120. doi: 10.18632/oncotarget.11258

Figure 3. Kaplan-Meier analyses for overall survival and recurrence free survival of patients in Fuhrman grade subgroups.

Figure 3

Overall survival for patients in the Fuhrman grade (1+2) group A., and (3+4) group B. according to ST6GalNAc-1 expression; recurrence free survival for patients in the Fuhrman grade (1+2) group C., and (3+4) group D. according to ST6GalNAc-1 expression; p-value was calculated by Log rank test, p<0.05 was regarded as statistically significant.